Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 666

1.

Raltegravir: the first HIV integrase inhibitor.

Cocohoba J, Dong BJ.

Clin Ther. 2008 Oct;30(10):1747-65. doi: 10.1016/j.clinthera.2008.10.012. Review.

PMID:
19014832
[PubMed - indexed for MEDLINE]
2.

Role of raltegravir in HIV-1 management.

Rokas KE, Bookstaver PB, Shamroe CL, Sutton SS, Millisor VE, Bryant JE, Weissman SB.

Ann Pharmacother. 2012 Apr;46(4):578-89. doi: 10.1345/aph.1Q616. Epub 2012 Apr 10. Review.

PMID:
22496475
[PubMed - indexed for MEDLINE]
3.

Treatment of HIV infection with raltegravir.

Chirch LM, Morrison S, Steigbigel RT.

Expert Opin Pharmacother. 2009 May;10(7):1203-11. doi: 10.1517/14656560902911488 . Review.

PMID:
19385721
[PubMed - indexed for MEDLINE]
4.

Integrase inhibitors: a novel class of antiretroviral agents.

Schafer JJ, Squires KE.

Ann Pharmacother. 2010 Jan;44(1):145-56. doi: 10.1345/aph.1M309. Epub 2009 Dec 29. Review.

PMID:
20040702
[PubMed - indexed for MEDLINE]
5.

Raltegravir: a review of its use in the management of HIV infection in treatment-experienced patients.

Croxtall JD, Keam SJ.

Drugs. 2009 May 29;69(8):1059-75. doi: 10.2165/00003495-200969080-00007. Review.

PMID:
19496631
[PubMed - indexed for MEDLINE]
6.

Raltegravir (MK-0518): an integrase inhibitor for the treatment of HIV-1.

Evering TH, Markowitz M.

Drugs Today (Barc). 2007 Dec;43(12):865-77. doi: 10.1358/dot.2007.43.12.1146063. Review.

PMID:
18174972
[PubMed - indexed for MEDLINE]
7.

Integrase inhibitors: a new treatment option for patients with human immunodeficiency virus infection.

Correll T, Klibanov OM.

Pharmacotherapy. 2008 Jan;28(1):90-101.

PMID:
18154479
[PubMed - indexed for MEDLINE]
8.

Raltegravir: an integrase inhibitor for HIV-1.

Evering TH, Markowitz M.

Expert Opin Investig Drugs. 2008 Mar;17(3):413-22. doi: 10.1517/13543784.17.3.413 . Review.

PMID:
18321239
[PubMed - indexed for MEDLINE]
9.

Discovery of raltegravir, a potent, selective orally bioavailable HIV-integrase inhibitor for the treatment of HIV-AIDS infection.

Summa V, Petrocchi A, Bonelli F, Crescenzi B, Donghi M, Ferrara M, Fiore F, Gardelli C, Gonzalez Paz O, Hazuda DJ, Jones P, Kinzel O, Laufer R, Monteagudo E, Muraglia E, Nizi E, Orvieto F, Pace P, Pescatore G, Scarpelli R, Stillmock K, Witmer MV, Rowley M.

J Med Chem. 2008 Sep 25;51(18):5843-55. doi: 10.1021/jm800245z.

PMID:
18763751
[PubMed - indexed for MEDLINE]
10.

Raltegravir: the first HIV type 1 integrase inhibitor.

Hicks C, Gulick RM.

Clin Infect Dis. 2009 Apr 1;48(7):931-9. doi: 10.1086/597290. Review.

PMID:
19231980
[PubMed - indexed for MEDLINE]
Free Article
11.

[Efficacy of raltegravir: from healthy volunteers to phase III trials].

Gatell JM.

Enferm Infecc Microbiol Clin. 2008 Nov;26 Suppl 12:29-33. Review. Spanish.

PMID:
19572423
[PubMed - indexed for MEDLINE]
12.

Raltegravir: new Drug. Alternative to enfuvirtide/darunavir in multidrug-resistant HIV.

[No authors listed]

Prescrire Int. 2008 Aug;17(96):135-7.

PMID:
19480091
[PubMed - indexed for MEDLINE]
13.

Raltegravir: the first HIV-1 integrase strand transfer inhibitor in the HIV armamentarium.

Nguyen BY, Isaacs RD, Teppler H, Leavitt RY, Sklar P, Iwamoto M, Wenning LA, Miller MD, Chen J, Kemp R, Xu W, Fromtling RA, Vacca JP, Young SD, Rowley M, Lower MW, Gottesdiener KM, Hazuda DJ.

Ann N Y Acad Sci. 2011 Mar;1222:83-9. doi: 10.1111/j.1749-6632.2011.05972.x. Review.

PMID:
21434946
[PubMed - indexed for MEDLINE]
14.

Rapid and durable antiretroviral effect of the HIV-1 Integrase inhibitor raltegravir as part of combination therapy in treatment-naive patients with HIV-1 infection: results of a 48-week controlled study.

Markowitz M, Nguyen BY, Gotuzzo E, Mendo F, Ratanasuwan W, Kovacs C, Prada G, Morales-Ramirez JO, Crumpacker CS, Isaacs RD, Gilde LR, Wan H, Miller MD, Wenning LA, Teppler H; Protocol 004 Part II Study Team.

J Acquir Immune Defic Syndr. 2007 Oct 1;46(2):125-33.

PMID:
17721395
[PubMed - indexed for MEDLINE]
15.

Safety and efficacy of the HIV-1 integrase inhibitor raltegravir (MK-0518) in treatment-experienced patients with multidrug-resistant virus: a phase II randomised controlled trial.

Grinsztejn B, Nguyen BY, Katlama C, Gatell JM, Lazzarin A, Vittecoq D, Gonzalez CJ, Chen J, Harvey CM, Isaacs RD; Protocol 005 Team.

Lancet. 2007 Apr 14;369(9569):1261-9.

PMID:
17434401
[PubMed - indexed for MEDLINE]
16.

Raltegravir as antiretroviral therapy in HIV/AIDS.

Sharma M, Walmsley SL.

Expert Opin Pharmacother. 2014 Feb;15(3):395-405. doi: 10.1517/14656566.2014.868884. Epub 2013 Dec 4. Review.

PMID:
24304203
[PubMed - indexed for MEDLINE]
17.

Raltegravir: a review of its pharmacokinetics, pharmacology and clinical studies.

Burger DM.

Expert Opin Drug Metab Toxicol. 2010 Sep;6(9):1151-60. doi: 10.1517/17425255.2010.513383. Review.

PMID:
20701552
[PubMed - indexed for MEDLINE]
18.

Antiretroviral activity, pharmacokinetics, and tolerability of MK-0518, a novel inhibitor of HIV-1 integrase, dosed as monotherapy for 10 days in treatment-naive HIV-1-infected individuals.

Markowitz M, Morales-Ramirez JO, Nguyen BY, Kovacs CM, Steigbigel RT, Cooper DA, Liporace R, Schwartz R, Isaacs R, Gilde LR, Wenning L, Zhao J, Teppler H.

J Acquir Immune Defic Syndr. 2006 Dec 15;43(5):509-15. Erratum in: J Acquir Immune Defic Syndr. 2007 Apr 1;44(4):492.

PMID:
17133211
[PubMed - indexed for MEDLINE]
19.

Raltegravir with optimized background therapy for resistant HIV-1 infection.

Steigbigel RT, Cooper DA, Kumar PN, Eron JE, Schechter M, Markowitz M, Loutfy MR, Lennox JL, Gatell JM, Rockstroh JK, Katlama C, Yeni P, Lazzarin A, Clotet B, Zhao J, Chen J, Ryan DM, Rhodes RR, Killar JA, Gilde LR, Strohmaier KM, Meibohm AR, Miller MD, Hazuda DJ, Nessly ML, DiNubile MJ, Isaacs RD, Nguyen BY, Teppler H; BENCHMRK Study Teams.

N Engl J Med. 2008 Jul 24;359(4):339-54. doi: 10.1056/NEJMoa0708975.

PMID:
18650512
[PubMed - indexed for MEDLINE]
Free Article
20.

Raltegravir, an HIV-1 integrase inhibitor for HIV infection.

Cabrera C.

Curr Opin Investig Drugs. 2008 Aug;9(8):885-98. Review.

PMID:
18666037
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk